New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)
Open Access
Abstract
We report the synthesis of several related 4-anilinoquinazolines as inhibitors of cardiac troponin I–interacting kinase (TNNi3K). These close structural analogs of 3-((6,7-dimethoxyquinazolin-4-yl)amino)-4-(dimethylamino)-N-methylbenzenesulfonamide (GSK114) provide new understanding of structure–activity relationships between the 4-anilinoquinazoline scaffold and TNNi3K inhibition. Through a small focused library of inhibitors, we observed that the N-methylbenzenesulfonamide was driving the potency in addition to the more traditional quinazoline hinge-binding motif. We also identified a compound devoid of TNNi3K kinase activity due to the addition of a methyl group in the hinge binding region. This compound could serve as a negative control in the study of TNNi3K biology. Small molecule crystal structures of several quinazolines have been solved, supporting observations made about overall conformation and TNNi3K inhibition.Keywords
This publication has 25 references indexed in Scilit:
- Kinase inhibitors: the road aheadNature Reviews Drug Discovery, 2018
- Substituent Effects on Drug–Receptor H-bond Interactions: Correlations Useful for the Design of Kinase InhibitorsJournal of Medicinal Chemistry, 2016
- GSK114: A selective inhibitor for elucidating the biological role of TNNI3KBioorganic & Medicinal Chemistry Letters, 2016
- Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)Journal of Medicinal Chemistry, 2015
- Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic HeartScience Translational Medicine, 2013
- Kinase Drug Discovery – What’s Next in the Field?ACS Chemical Biology, 2012
- A public-private partnership to unlock the untargeted kinomeNature Chemical Biology, 2012
- Adenovirus‐mediated overexpression of cardiac troponin I‐interacting kinase promotes cardiomyocyte hypertrophyClinical and Experimental Pharmacology and Physiology, 2011
- Tnni3k Modifies Disease Progression in Murine Models of CardiomyopathyPLOS Genetics, 2009
- The Protein Kinase Complement of the Human GenomeScience, 2002